Apyx Medical (APYX) Gross Profit (2011 - 2026)

Apyx Medical's Gross Profit history runs 16 years deep, the most recent figure standing at $7.9 million for Q1 2026.

• Quarterly Gross Profit rose 39.89% year-over-year to $7.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.3 million (up 21.42% YoY) and the FY2025 annual result came in at $33.0 million, up 12.55% from the prior year.
• Gross Profit was $7.9 million for Q1 2026 at Apyx Medical, down from $12.0 million in the prior quarter.
• Across five years, Gross Profit topped out at $12.0 million in Q4 2025 and bottomed at $5.7 million in Q1 2025.
• A 5-year average of $7.8 million and a median of $7.9 million in 2026 frame the typical range for Gross Profit.
• Peak annual rise in Gross Profit reached 40.26% in 2022, while the deepest fall reached 32.18% in 2022.
• Apyx Medical's Gross Profit stood at $8.2 million in 2022, then grew by 8.35% to $8.9 million in 2023, then grew by 0.39% to $9.0 million in 2024, then jumped by 33.86% to $12.0 million in 2025, then slumped by 33.95% to $7.9 million in 2026.
• Business Quant data shows APYX's Gross Profit at $7.9 million in Q1 2026, $12.0 million in Q4 2025, and $8.3 million in Q3 2025.